Verastem Oncology’s Collaboration with GenFleet Therapeutics

Ropes & Gray advised Verastem Oncology on the deal.Verastem Oncology (Nasdaq: VSTM) announced that the company has entered into a discovery and development collaboration with GenFleet…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Pietro Martinoia

This content is for Standard 1 Year members only.
Login Join Now